TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36210628

Group type: EXPERIMENTAL
Intervention: Incidental (INC) irradiation
Number of subjects: 487

Group type: COMPARATOR
Intervention: Intentional (INT) irradiation
Number of subjects: 487
Study: 33279397

Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Occlusal splints
Number of subjects: 34
Study: 35474624

Group type: EXPERIMENTAL
Intervention: CBT4BN (internet-based cognitive-behavioral therapy)
Number of subjects: 149

Group type: COMPARATOR
Intervention: CBTF2F (face-to-face cognitive-behavioral therapy)
Number of subjects: 149
Study: 34114174

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 35275751

Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao acupuncture (AG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study: 33989559

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks combined with cetuximab 400 mg/m2 intravenously (initial loading dose) followed by 250 mg/m2 intravenously weekly.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks combined with cetuximab 400 mg/m2 intravenously followed by 250 mg/m2 intravenously weekly.
Number of subjects: 33
Study: 35434257

Group type: EXPERIMENTAL
Intervention: Pre-inflation group (balloon massaging with preliminary extracorporeal balloon inflation in saline water)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 98
Study: 34705542

Group type: EXPERIMENTAL
Intervention: 3.0 g of FO n3 supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36314980

Group type: EXPERIMENTAL
Intervention: Preoperative umbilicus preparation 30 minutes before surgery
Number of subjects: 400

Group type: COMPARATOR
Intervention: No preoperative umbilicus preparation (control group)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups underwent TU-LESS surgery
Number of subjects: 400
Study: 32028083

Group type: EXPERIMENTAL
Intervention: hydrocortisone
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: yohimbine and hydrocortisone
Number of subjects: 104

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 104
Study: 34586628

Group type: EXPERIMENTAL
Intervention: Relationship education
Number of subjects: 1367
Study: 33299400

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) plus physical therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Baseline level of UE-FM
Number of subjects: 80
Study: 33859386

Group type: EXPERIMENTAL
Intervention: Deep learning predicted HER2-specific subset from computational library of trastuzumab variants (approximately 1 x 10^108 variants)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deep-sequenced libraries of trastuzumab variants (about 1 x 10^4 variants)
Number of subjects: 30
Study: 32005066

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR) pretreatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no IVR pretreatment)
Number of subjects: 50
Study: 35245011

Group type: EXPERIMENTAL
Intervention: PEG-rhGH 0.12 mg/kg/w
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PEG-rhGH 0.20 mg/kg/w
Number of subjects: 48

Group type: COMPARATOR
Intervention: daily rhGH 0.28 mg/kg/w
Number of subjects: 48
Study: 34634925

Group type: EXPERIMENTAL
Intervention: Antiplatelet pretreatment
Number of subjects: 4881

Group type: COMPARATOR
Intervention: No antiplatelet pretreatment
Number of subjects: 4881

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy
Number of subjects: 4881
Study: 32746639

Group type: EXPERIMENTAL
Intervention: Bright white light (BWL) for 30 minutes daily for 8 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Dim red light (DRL) for 30 minutes daily for 8 weeks
Number of subjects: 51
Study: 32294620

Group type: COMPARATOR
Intervention: Control with intentional hydration (1 L of water the previous night, 500 mL 60 min before intervention, and 1 mL for each 1 g of body mass lost immediately after intervention)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control without intentional hydration (ad libitum water ingestion before intervention)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise with intentional hydration (cycle ergometer, 45 min, 50% of VO2peak)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise without intentional hydration
Number of subjects: 18
Study: 35436934

Group type: EXPERIMENTAL
Intervention: Distance Learning (DL)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Face-to-Face (F-F)
Number of subjects: 118
Study: 32053464

Group type: EXPERIMENTAL
Intervention: Various interventions in school physical education, duration ranging from 5 min to 2 years.
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Experimental studies with randomized controlled trial design, specific interventions not detailed.
Number of subjects: 71
Study: 32196413

Group type: EXPERIMENTAL
Intervention: General family social support
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: General family social support and its subscales (information support, seeking support, instrumental support)
Number of subjects: 163
Study: 36286665

Group type: EXPERIMENTAL
Intervention: Glucocorticosteroid hormones (GCS), specifically dexamethasone, used as an anti-inflammatory treatment for critically ill patients with COVID-19.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucocorticosteroid hormones (GCS) in patients with COVID-19 outside critical conditions.
Number of subjects: 0
Study: 32043343

Group type: EXPERIMENTAL
Intervention: 90% HRmax
Number of subjects: 19

Group type: COMPARATOR
Intervention: 60% HRmax
Number of subjects: 19
Study: 32356505

Group type: EXPERIMENTAL
Intervention: Calf massage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control rest period (placebo)
Number of subjects: 20
Study: 32311799

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Chemotherapy regimens combined with trastuzumab
Number of subjects: 364
Study: 36229177

Group type: EXPERIMENTAL
Intervention: 0.01% atropine + spectacles
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Ortho-k + placebo
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo drops + spectacles (control)
Number of subjects: 164
Study: 34871789

Group type: EXPERIMENTAL
Intervention: Individualized implementation support
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Group implementation support
Number of subjects: 1097
Study: 33386634

Group type: EXPERIMENTAL
Intervention: Test-guided dietary advice
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 84
Study: 35771366

Group type: EXPERIMENTAL
Intervention: mrTRG-directed management (intervention arm)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control arm (standard management)
Number of subjects: 96
Study: 33185927

Group type: EXPERIMENTAL
Intervention: Fractional Er:YAG laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fractional Microneedling Radiofrequency (FMR)
Number of subjects: 20
Study: 33142168

Group type: EXPERIMENTAL
Intervention: Hyperthermic environment (37 °C)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Thermo-neutral environment (25 °C)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both environments (25 °C and 37 °C)
Number of subjects: 21
Study: 33023430

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 8
Study: 36352377

Group type: EXPERIMENTAL
Intervention: Diabetes distress e‐learning
Number of subjects: 74

Group type: COMPARATOR
Intervention: Diabetes distress chapter (active control)
Number of subjects: 74
Study: 35560945

Group type: EXPERIMENTAL
Intervention: Cross-sectional modified dissection approach
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Cross-sectional dissection approach
Number of subjects: 1
Study: 32040959

Group type: EXPERIMENTAL
Intervention: Maraviroc (300 mg twice daily for 72 weeks)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo (standard c-ART)
Number of subjects: 416
Study: 35443651

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional manual therapy (Control)
Number of subjects: 48
Study: 34645870

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Moderate-risk group
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 1002
Study: 32640131

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention administered by specially trained nurses
Number of subjects: 5441

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 5441
Study: 34396874

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg 1 hour before surgery
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 33040772

Group type: EXPERIMENTAL
Intervention: Dietary intervention focused on 'eating for the gut microbiota'
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (dietary advice from healthcare provider)
Number of subjects: 45
Study: 35941536

Group type: EXPERIMENTAL
Intervention: Oxycodone (group O)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Hydromorphone (group H)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Sufentanil (group S)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 555
Study: 33427559

Group type: EXPERIMENTAL
Intervention: Increased dietary phosphorus intake (100 mg)
Number of subjects: 34
Study: 35766690

Group type: EXPERIMENTAL
Intervention: Tonsillotomy
Number of subjects: 134

Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 134
Study: 36183738

Group type: COMPARATOR
Intervention: Penicillamine
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: TETA4
Number of subjects: 53
Study: 33342317

Group type: COMPARATOR
Intervention: IPL
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IPL + MGX
Number of subjects: 100
Study: 32584806

Group type: EXPERIMENTAL
Intervention: Traditional treatments (incisions, tourniquets, black-stones)
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Consulting traditional healers
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Antivenom use
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Long-term disabilities
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Snakebite incidence
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Case-fatality rate
Number of subjects: 9924

Group type: EXPERIMENTAL
Intervention: Severity signs
Number of subjects: 9924
Study: 35200040

Group type: EXPERIMENTAL
Intervention: Rivaroxaban and clopidogrel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Warfarin, clopidogrel, and aspirin
Number of subjects: 100
Study: 32179516

Group type: EXPERIMENTAL
Intervention: Evacetrapib
Number of subjects: 8236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8236
Study: 36307892

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) - 5 fractions of 8 Gy
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 174
Study: 33331206

Group type: EXPERIMENTAL
Intervention: SHR0534 at doses of 10, 25, 50, or 100 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SHR0534 at 5 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: SHR0534
Number of subjects: 51
Study: 32428844

Group type: EXPERIMENTAL
Intervention: Vidofludimus calcium (IMU-838)
Number of subjects: 0
Study: 35698162

Group type: EXPERIMENTAL
Intervention: Stepwise swallowing training (SST) program, integrated with all swallowing organs movement, duration of 4 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine dysphagia care (Control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stepwise swallowing training (SST) program.
Number of subjects: 0
Study: 35798138

Group type: EXPERIMENTAL
Intervention: Cassia fistula syrup (CFS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 70
Study: 33766820

Group type: EXPERIMENTAL
Intervention: Nasal fentanyl (NF) administered by lay carers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buccal midazolam (BM) administered by lay carers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard breakthrough medication administered by healthcare professionals
Number of subjects: 0
Study: 32310680

Group type: EXPERIMENTAL
Intervention: 0.05% w/w ECa 233 gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study: 35984704

Group type: EXPERIMENTAL
Intervention: CT900 at a dose of 12 mg/m2 every 2 weeks (q2Wk)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: CT900 at a dose of 12 mg/m2/q2Wk
Number of subjects: 109
Study: 34237156

Group type: EXPERIMENTAL
Intervention: Beck Scale for Suicide Ideation (BSSI)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Columbia‐Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: suicide item of the Hamilton Rating Scale for Depression (HRSD)
Number of subjects: 101
Study: 32482970

Group type: EXPERIMENTAL
Intervention: Guanfacine Extended Release (GXR) 1-7 mg/d
Number of subjects: 1084

Group type: EXPERIMENTAL
Intervention: Guanfacine Extended Release (GXR) 1-4 mg/d
Number of subjects: 1084
Study: 35044235

Group type: EXPERIMENTAL
Intervention: 4.7F stent
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 7.0F stent
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no stent)
Number of subjects: 12
Study: 32032231

Group type: EXPERIMENTAL
Intervention: Traditional Squat Bar (TRAD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Safety Squat Bar (SSB)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both TRAD and SSB
Number of subjects: 32
Study: 35244344

Group type: EXPERIMENTAL
Intervention: ephedrine + caffeine (EC)
Number of subjects: 142

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 142
Study: 32618522

Group type: EXPERIMENTAL
Intervention: Endoscope
Number of subjects: 72

Group type: COMPARATOR
Intervention: Microscope
Number of subjects: 72
Study: 37897465

Group type: EXPERIMENTAL
Intervention: Esophagus deviation device + luminal esophageal temperature (LET) monitoring
Number of subjects: 120

Group type: COMPARATOR
Intervention: Luminal esophageal temperature (LET) monitoring alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (LET monitoring)
Number of subjects: 120
Study: 33506643

Group type: COMPARATOR
Intervention: CHADS2 score
Number of subjects: 2202

Group type: COMPARATOR
Intervention: R2CHADS2 score
Number of subjects: 2202

Group type: COMPARATOR
Intervention: CHA2DS2-VASc score
Number of subjects: 2202
Study: 32728820

Group type: EXPERIMENTAL
Intervention: Exercise training (EX, n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (CTRL, n=19)
Number of subjects: 39
Study: 33487060

Group type: EXPERIMENTAL
Intervention: Anterior locking plate
Number of subjects: 159

Group type: COMPARATOR
Intervention: Closed reduction and cast immobilization (Control)
Number of subjects: 159
Study: 32925571

Group type: EXPERIMENTAL
Intervention: Enhanced support (follow-up with a trained peer supporter)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine support (no further follow-up)
Number of subjects: 50
Study: 32993779

Group type: EXPERIMENTAL
Intervention: General health education
Number of subjects: 3788

Group type: EXPERIMENTAL
Intervention: Personalised health education
Number of subjects: 3788
Study: 35485464

Group type: EXPERIMENTAL
Intervention: Spinous process stabilization using the microplate/screw system
Number of subjects: 360
Study: 32520816

Group type: EXPERIMENTAL
Intervention: Pain Psychology and Neuroscience (PPN) intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Matched, active education control condition
Number of subjects: 104
Study: 35441440

Group type: EXPERIMENTAL
Intervention: Tregs + rituximab
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tregs only
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 33356676

Group type: EXPERIMENTAL
Intervention: 50% O2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 80% O2
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30% O2
Number of subjects: 60
Study: 32789935

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) adjunctive to conventional therapy, 30 sessions, twice daily over 3 weeks (group A)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) adjunctive to conventional therapy, 30 sessions, once daily over 6 weeks (group B)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional therapy without HBOT (group C)
Number of subjects: 81
Study: 35571272

Group type: EXPERIMENTAL
Intervention: Seed storage time
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative traits
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Analysis of variance
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Genetic advance, heritability, and genotypic coefficient of variation
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Identified high yielding varieties
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clustering analysis
Number of subjects: 31
Study: 34266435

Group type: EXPERIMENTAL
Intervention: Lycopene
Number of subjects: 20

Group type: COMPARATOR
Intervention: Corticosteroids (Prednisolone)
Number of subjects: 20
Study: 33126918

Group type: EXPERIMENTAL
Intervention: Stuck-moving needle acupuncture
Number of subjects: 108

Group type: COMPARATOR
Intervention: Common acupuncture
Number of subjects: 108

Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 108
Study: 34974818

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Concentric exercise (CON)
Number of subjects: 17
Study: 33915011

Group type: EXPERIMENTAL
Intervention: Discharge care bundle including medication reconciliation, counselling session and documentation transfer to primary care physician (PCP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 120
Study: 32344491

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short sleep duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequently insomnia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long sleep duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morningness
Number of subjects: 0
Study: 35883044

Group type: EXPERIMENTAL
Intervention: Sustained cord circulation And Ventilation (SAVE-method)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation outcomes from electronic surveys
Number of subjects: 0
Study: 33495363

Group type: EXPERIMENTAL
Intervention: ATRA-ATO
Number of subjects: 855

Group type: COMPARATOR
Intervention: ATRA-anthracycline
Number of subjects: 855
Study: 36007937

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management aimed at reducing systolic BP to <120 mm Hg
Number of subjects: 9329
Study: 34229972

Group type: EXPERIMENTAL
Intervention: Endoscopic drainage (using either lumen apposing metal stents (LAMS) or plastic stents tailored to the amount of necrotic debris)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic drainage
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endoscopic drainage
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 36461019

Group type: EXPERIMENTAL
Intervention: Parenting intervention through CCD group sessions (5 educational group sessions, each lasting 45 minutes)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 181
Study: 32545440

Group type: EXPERIMENTAL
Intervention: Endomeatal approach (EMA)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Posterior tympanotomy (PT)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 202
Study: 33998345

Group type: EXPERIMENTAL
Intervention: Simple interrupted (SI) suture pattern
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple continuous (SC) suture pattern
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cruciate (XT) suture pattern
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unidirectional knotless continuous barbed suture (SF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35462561

Group type: EXPERIMENTAL
Intervention: 23Na MRI
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 23Na MRI and DWI
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 3

Group type: COMPARATOR
Intervention: Inward Na+ conductance inhibitors (cariporide, eslicarbazepine acetate)
Number of subjects: 3
Study: 32561928

Group type: EXPERIMENTAL
Intervention: HIV retesting with DNA polymerase chain reaction (PCR) performed if initial tests are discrepant.
Number of subjects: 4451
Study: 33013705

Group type: EXPERIMENTAL
Intervention: Weight loss and exercise (WL + EX)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss (WL)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Health education control (HED)
Number of subjects: 3
Study: 33971837

Group type: EXPERIMENTAL
Intervention: Full immunization status
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Geographic cluster of under immunization
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Maternal Tetanus Toxoid immunization status
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Place of delivery
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Specific vaccines (Polio, BCG, DPT (1-3), Measles)
Number of subjects: 482
Study: 36781490

Group type: EXPERIMENTAL
Intervention: VPZ 3 weeks
Number of subjects: 234

Group type: COMPARATOR
Intervention: VPZ 8 weeks
Number of subjects: 234
Study: 34427217

Group type: EXPERIMENTAL
Intervention: Subthreshold green laser (STL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 30